NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Thursday that its Q1 revenues rose 23 percent year over year.

For the three months ended March 31, total revenues were $18.1 million compared to $14.7 million in the prior year period, beating the average Wall Street analyst estimate of $17.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.